CompaniesAFYA
S1Overview
AFYA
Afya Limited
HealthcareMedical EducationBrazilTake-Private Risk
$14.00+1.4%
Market Cap
$1.30B
SEC 20-F
P/E (TTM)
11.0×
via financials
Rev Growth YoY
12.0%
+12%SEC filing
Gross Margin
64.3%
SEC filing
FCF Yield
42.1%
calculated
Upside to FV
—
vs fair value
Conviction
2/5Brazilian medical-education platform at a 42.1% FCF yield — but Bertelsmann controls 90.5% of votes and a lowball take-private is the base case.
Research Depth
ScreeningDeep DiveFull Model
Updated 22d ago
S2Thesis
Afya operates medical schools and digital health-education in Brazil. Cheap on a 42.1% FCF yield with 64.3% gross margins, but Bertelsmann + Esteves control 90.5% of votes and bought in at $26.90 — a take-private at $18–20 (still below their cost) is the base case. Phase 1.
Bull Case
[awaiting: bull — Phase 2]Bear Case
[awaiting: bear — Phase 2]S3Key Metrics
Market Cap
$1.30B
SEC 20-F
Enterprise Value
$1.60B
calculated
Revenue (TTM)
$700M
SEC filing
P/E (TTM)
11.0×
via financials
Forward P/E
9.0×
consensus
P/S (TTM)
1.9×
via financials
P/B
1.7×
via financials
EV/EBITDA
7.0×
calculated
PEG
0.5×
calculated
Revenue Growth
12.0%
SEC filing
Gross Margin
64.3%
SEC filing
Operating Margin
25.0%
SEC filing
Net Margin
15.0%
SEC filing
Free Cash Flow
$130M
SEC filing
FCF Yield
42.1%
calculated
Debt / Equity
0.6×
SEC filing
Current Ratio
1.2×
SEC filing
Short Interest
[awaiting: exchange]
exchange
Institutional Own.
[awaiting: 13F]
13F
Insider Own.
[awaiting: proxy]
proxy
Shares Out.
93.0M
SEC filing
Float
30.0M
exchange
S4Valuation
Price vs Fair Value
Valuation pending
Scenario fair-value range awaiting model.
DCF Summary
DCF awaiting Phase 2+
Discounted cash-flow model is built once research reaches Deep Dive.
Historical Multiples
Multiple history pending
This section is being deepened.
Peer Comparison
Peer set pending
Comparable companies awaiting selection.
S5Financials
Income statement pending
Awaiting SEC filing backfill.
Balance sheet pending
Awaiting SEC filing backfill.
Cash flow pending
Awaiting SEC filing backfill.
Phase 1.
S6Catalysts
Catalyst calendar pending
Upcoming events awaiting research.
S7Risks
Risk matrix pending
This section is being deepened.
S8Technical Snapshot
Technical snapshot pending
Price levels and indicators awaiting data.
S9Ownership & Insider Activity
Top Institutional Holders via 13F filings
13F holdings pending
Institutional holder detail awaiting filing.
Insider Activity
Insider transactions pending
This section is being deepened.
S10Peer Comparison
Peer set pending
Comparable companies awaiting selection.
S11Research Notes
2026-05-25Internal
Take-private setup
Control holders 90.5% of votes; Cayman incorporation = weak minority protection.